HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keiko Suzuki Selected Research

CCR3 Receptors

6/2007A dual antagonist for chemokine CCR3 receptor and histamine H1 receptor.
4/2006A novel, selective, and orally available antagonist for CC chemokine receptor 3.
1/2006In vitro and in vivo characterization of a novel CCR3 antagonist, YM-344031.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keiko Suzuki Research Topics

Disease

11Neoplasms (Cancer)
03/2018 - 05/2005
8Inflammation (Inflammations)
10/2016 - 07/2004
5Infections
12/2019 - 04/2006
5Bone Resorption
06/2019 - 03/2006
4Metabolic Bone Diseases (Osteopenia)
06/2019 - 03/2006
4Asthma (Bronchial Asthma)
06/2007 - 07/2004
3Osteoporosis
09/2019 - 01/2014
3Sepsis (Septicemia)
06/2019 - 05/2016
3Carcinoma (Carcinomatosis)
11/2017 - 02/2005
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2015 - 05/2009
3Lung Neoplasms (Lung Cancer)
07/2009 - 09/2007
3Atopic Dermatitis (Atopic Eczema)
06/2007 - 07/2004
2COVID-19
04/2022 - 01/2021
2Acquired Immunodeficiency Syndrome (AIDS)
02/2021 - 05/2015
2Critical Illness (Critically Ill)
01/2021 - 01/2021
2Alzheimer Disease (Alzheimer's Disease)
01/2019 - 01/2016
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 09/2018
2Glioblastoma (Glioblastoma Multiforme)
07/2016 - 01/2009
2Disease Progression
03/2015 - 02/2004
2Respiratory Tract Infections (Respiratory Tract Infection)
10/2012 - 09/2012
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
03/2010 - 10/2009
2Lymphoma (Lymphomas)
03/2010 - 02/2003
2Secondary Hyperparathyroidism
01/2010 - 01/2010
2Motor Disorders
05/2009 - 09/2007
2Hemorrhage
01/2007 - 10/2006
2Rhinitis
04/2006 - 07/2004
2Retinal Vein Occlusion
03/2005 - 02/2004
1Thrombosis (Thrombus)
01/2021
1Portal Hypertension
01/2021
1Disseminated Intravascular Coagulation
01/2021
1Hypopituitarism (Sheehan's Syndrome)
01/2021
1Multiple Organ Failure (MODS)
01/2021
1Congenital Heart Defects (Congenital Heart Defect)
01/2021
1Connective Tissue Diseases (Connective Tissue Disease)
01/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2021
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2021
1Chronic Renal Insufficiency
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Heart Failure
01/2021
1Endotoxemia
01/2021
1Vasculitis (Vasculitides)
01/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2021
1Muscle Weakness
10/2020
1Rhinosinusitis
11/2019
1Nasal Polyps (Nasal Polyp)
11/2019

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
08/2018 - 05/2005
5Messenger RNA (mRNA)IBA
05/2013 - 02/2006
4Pharmaceutical PreparationsIBA
01/2021 - 06/2007
3Syndecan-1 (Syndecan 1)IBA
01/2021 - 01/2021
3Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2009
3Diphosphonates (Bisphosphonates)IBA
01/2019 - 03/2006
3Anti-Bacterial Agents (Antibiotics)IBA
11/2017 - 09/2012
3SteroidsIBA
01/2015 - 02/2004
3MacrolidesIBA
10/2012 - 06/2003
3LipidsIBA
10/2012 - 02/2006
3CCR3 ReceptorsIBA
06/2007 - 01/2006
2Anthocyanins (Anthocyanin)IBA
09/2019 - 01/2014
2delphinidinIBA
09/2019 - 01/2014
2Amyloid (Amyloid Fibrils)IBA
01/2019 - 01/2016
2Cisplatin (Platino)FDA LinkGeneric
09/2017 - 11/2010
2Monoclonal AntibodiesIBA
07/2016 - 06/2011
2ChromatinIBA
03/2015 - 04/2006
2Carboplatin (JM8)FDA LinkGeneric
11/2010 - 12/2009
2ChemokinesIBA
09/2010 - 06/2007
2Chemokine ReceptorsIBA
09/2010 - 02/2003
2Rituximab (Mabthera)FDA Link
03/2010 - 10/2009
2Vincristine (Oncovin)FDA LinkGeneric
03/2010 - 10/2009
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
03/2010 - 10/2009
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2010 - 10/2009
2Anesthetics (Anesthetic Agents)IBA
02/2010 - 10/2006
2Parathyroid Hormone (Parathormone)IBA
01/2010 - 01/2010
2Prednisolone (Predate)FDA LinkGeneric
10/2009 - 09/2007
2ErbB Receptors (EGF Receptor)IBA
07/2009 - 09/2007
2Gefitinib (Iressa)FDA Link
07/2009 - 09/2007
2Hemoglobins (Hemoglobin)IBA
05/2008 - 01/2008
2ProstaglandinsIBA
04/2008 - 02/2006
2Peptide Hydrolases (Proteases)FDA Link
01/2008 - 01/2007
2AntigensIBA
01/2007 - 07/2004
2LigandsIBA
04/2006 - 02/2003
2CC ChemokinesIBA
04/2006 - 04/2002
2methyl 2- O- alpha- rhamnopyranosyl- beta- galactopyranosideIBA
03/2005 - 02/2004
1casirivimab and imdevimab drug combinationIBA
04/2022
1Combined Antibody TherapeuticsIBA
04/2022
1fibrin fragment D (D-dimer)IBA
01/2021
1Growth Hormone (Somatotropin)IBA
01/2021
1AntithrombinsIBA
01/2021
1germineIBA
10/2020
14-Aminopyridine (4 Aminopyridine)FDA Link
10/2020
1VancomycinFDA LinkGeneric
12/2019
1Mucin 5ACIBA
11/2019
1petunidinIBA
06/2019
1Antifungal AgentsIBA
06/2019
1Staphylococcal Protein A (Protein A)IBA
01/2019

Therapy/Procedure

11Therapeutics
04/2022 - 06/2003
6Drug Therapy (Chemotherapy)
09/2017 - 11/2004
2Renal Dialysis (Hemodialysis)
01/2010 - 05/2008
1Hearing Aids (Hearing Aid)
02/2021
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2021
1Critical Care (Surgical Intensive Care)
01/2021
1Lasers (Laser)
05/2019